皮康王品牌怎么样 申请店铺

我要投票 皮康王在保健药品行业中的票数:292 更新时间:2025-05-13
皮康王是哪个国家的品牌?「皮康王」是 拜耳医药保健有限公司 旗下著名品牌。该品牌发源于云南省昆明市,在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力皮康王品牌出海!将品牌入驻外推网,定制皮康王品牌推广信息,可以显著提高皮康王产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

皮康王怎么样


“皮康王”最初由上海部队院校研制成功,具有神秘的军队血统。曾因帮助老山前线部队解决了因湿热环境引发的脚癣、体癣、股癣及皮肤瘙痒等问题,被誉为“皮疾克星”。后在国家政策放开的情况下由滇虹药业最早获得“军转民”的生产资格,于1993年隆重上市。

滇虹药业集团前身为中美合资昆明滇虹药业有限公司,系由滇虹天然药物厂与美国大东企业于1997年合资设立,承继1993年注册成立的滇虹天然药物厂的全部业务,设立至今始终由中方控股。2012年,昆明滇虹药业有限公司改制变更为滇虹药业集团股份有限公司。2014年3月,拜耳集团完成对滇虹药业集团公司所有股份的收购。滇虹药业集团公司正式成为拜耳集团子公司。

滇虹药业集团是一家研发导向型、集研发、生产和营销为一体的现代化制药企业集团。滇虹药业现有员工3000余名,营销网络覆盖全国乃至东南亚国家及非洲地区。作为云药产业发展的中坚力量,滇虹药业勇于创新、积极开拓,已成长为中国医药行业的知名企业。

通过持续的品牌建设,滇虹药业主品牌“康王”以其广泛的美誉度和影响力,经国家工商行政管理总局及最高人民法院联合认定为“中国驰名商标”,同时上榜“亚洲最具价值500强品牌”。集团旗下产品以质量可靠、疗效确切赢得众多患者青睐。其中包括被誉为“去屑专家”的“康王发用洗剂”以及被誉为“皮疾克星”的“皮康王”、妇科知名产品“丹莪妇康煎膏”等一批享誉国内外的品牌产品。

伴随企业社会知名度和美誉度的不断提升,公司正式确立了植根于品牌的“以消费者大健康产业为主体,以拓展医药及国际市场为两翼”的“一体两翼”消费者大健康产业发展战略。在这一战略指引下,滇虹药业积极推动中国负责任的自我保健及自我药疗事业进程,推动设立国际自我保健日。同时展开产业整合,打造中药标准化平台,集中优势资源将民族品牌做强做大。

滇虹药业被国家五部委联合认定为“国家级企业技术中心”,被云南省人民政府列为“省重点制药企业”,被中华全国工商联和国家税务总局评为“诚信纳税”企业,被全国总工会和中华全国工商联评为“双爱双评”先进企业。多次荣获国家有关部委、省市区各级政府表彰奖励,多次接待国家和国外领导人、省市领导的参观访问。

依托高质量的产品优势和良好的企业文化积淀,滇虹药业气势如虹,开疆拓土,在大健康产业领域以良好的发展态势傲视同侪。秉持“以人为本、艰苦奋斗、科技兴药”的企业理念,怀着“关注健康,造福人类”的企业追求,滇虹愿与社会各界人士携手,共襄医药产业美好未来。


"King Picon" was originally developed by Shanghai military academy, which has a mysterious military pedigree. He once helped Laoshan front-line army to solve the problems of tinea cruris, tinea corporis, tinea cruris and pruritus caused by humid and hot environment, which was known as "skin disease killer". After the opening of the national policy, Dian Hong pharmaceutical industry was the first to obtain the qualification of "military to civilian" production, which was solemnly listed in 1993. Yunnan Hong Pharmaceutical Group, formerly known as Sino US joint venture Kunming Yunnan Hong Pharmaceutical Co., Ltd., is a joint venture established by Yunnan Hong Natural Pharmaceutical Co., Ltd. and Dadong enterprise of the United States in 1997. It inherits all businesses of Yunnan Hong Natural Pharmaceutical Co., Ltd. registered in 1993 and has been controlled by China ever since its establishment. In 2012, the restructuring of Kunming Dianhong Pharmaceutical Co., Ltd. was changed to Dianhong Pharmaceutical Group Co., Ltd. In March 2014, Bayer Group completed the acquisition of all shares of Dianhong Pharmaceutical Group. Dianhong pharmaceutical group company has officially become a subsidiary of Bayer Group. Dianhong Pharmaceutical Group is a R & D-oriented, research and development, production and marketing as one of the modern pharmaceutical enterprise groups. Dianhong pharmaceutical has more than 3000 employees, and its marketing network covers the whole country, even Southeast Asian countries and Africa. As the backbone of the development of Yunnan pharmaceutical industry, Dianhong pharmaceutical industry has the courage to innovate and actively explore, and has grown into a well-known enterprise in China's pharmaceutical industry. Through continuous brand building, the owner brand of Dianhong Pharmaceutical Co., Ltd. "Kangwang", with its extensive reputation and influence, was jointly recognized as "China's famous trademark" by the State Administration for Industry and Commerce and the Supreme People's court, and listed as "the most valuable 500 brands in Asia". The group's products have won the favor of many patients with reliable quality and exact curative effect. Among them, "Kangwang hair lotion" which is known as "Dandruff removal expert" and "picongwang" which is known as "pixixing" and "Dane Fukang Decoction", which is a famous gynecological product, are well-known brand products at home and abroad. With the continuous improvement of corporate social popularity and reputation, the company has officially established the "one body and two wings" development strategy of consumer health industry, which is rooted in the brand and takes the consumer health industry as the main body and the expansion of medicine and international market as the two wings. Under the guidance of this strategy, Dianhong pharmaceutical actively promotes China's responsible self-care and self medication career, and promotes the establishment of the international self care day. At the same time, we will carry out industrial integration, build a platform for standardization of traditional Chinese medicine, and focus on advantageous resources to strengthen and expand national brands. Dianhong pharmaceutical industry is jointly recognized as "national enterprise technology center" by five ministries and commissions of the state, as "provincial key pharmaceutical enterprise" by Yunnan Provincial People's government, as "honest tax payment" enterprise by all China Federation of industry and Commerce and State Administration of Taxation, and as "double love and double evaluation" advanced enterprise by all China Federation of trade unions and all China Federation of industry and commerce. It has won many awards from relevant national ministries and commissions, provincial and municipal governments at all levels, and received many visits from national and foreign leaders and provincial and municipal leaders. Relying on the advantages of high-quality products and good corporate culture accumulation, Dianhong pharmaceutical industry is in a great momentum, expanding its territory and dominating its peers in the field of big health industry with a good development momentum. Adhering to the enterprise philosophy of "people-oriented, hard work, science and technology to promote medicine" and the enterprise pursuit of "focusing on health and benefiting mankind", Dianhong is willing to work with people from all walks of life to share the bright future of medicine industry.

本文链接: https://brand.waitui.com/3539f7c8f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

思特威:已布局机器人应用系列CMOS图像传感器

5月13日,思特威负责人在第十五届松山湖中国IC创新高峰论坛介绍,公司基于SmartGS™-2 Plus技术平台已布局机器人应用系列CMOS图像传感器,可以用于机器人空间定位与避障,具有高分辨率、高快门效率、高动态范围、低噪音等优势;另外,子公司飞凌微AI SoC芯片可以提供双目深度视觉解决方案,满足彩色图像处理和深度计算需求,适用于机器人、机器狗。(证券时报)

2小时前

谷歌:正在沙特建设数据中心,并引入GPU

谷歌总裁兼首席信息官表示,正在沙特建设数据中心,并引入GPU。(财联社)

2小时前

固收老将马龙去向确定,已正式加入天弘基金

原招商基金首席固定收益投资官、基金经理马龙已正式加盟天弘基金。马龙拥有近16年债券投研经历和近11年的公募基金管理经验,其管理规模在2024年二季度末时高达876.18亿元。今年4月,马龙已清仓式卸任所有基金产品。据悉,待静默期结束之后,马龙在天弘基金将继续从事基金管理工作。(财联社)

2小时前

马明哲回应中国平安500亿元融资计划

5月13日下午,中国平安2024年年度股东大会上,中国平安管理层回应投资者关于发债融资的提问时表示,平安根据市场情况进行债务融资,计划在境内一次或分多次发行本金不超(含)500亿元人民币债券融资工具,包括但不限于资本补充债券、金融债券、公司债券及其他监管机构许可发行的境内人民币债券融资工具。在低利率环境中,此举有助于提升集团未来的资本灵活性,也有助于提升资本回报ROE。中国平安董事长马明哲对此补充,管理层珍惜股东每一分钱,希望资本可以发挥最大的价值。金融、医疗行业的发展前景很好,资本规划需要兼顾不同时期,管理层也希望在资本的筹集和使用方面可以兼顾各方面意见。(证券时报)

2小时前

中邮保险资管:正在申请保险资金长期投资试点资格

近日,金融监管总局局长李云泽在国新办举行的新闻发布会上宣布,未来将进一步扩大保险资金长期投资改革试点范围,近期拟再批复600亿元。目前,中邮保险资管正在积极争取保险资金长期投资试点三期资格。中邮保险资管相关人士对财联社记者表示,保险机构设立私募证券投资基金是推动保险资金入市,发挥险资长期资本优势的有益尝试,获批后将践行长期投资理念,发挥耐心资本引领作用。(财联社)

2小时前

本页详细列出关于皮康王的品牌信息,含品牌所属公司介绍,皮康王所处行业的品牌地位及优势。
咨询